PH12013501632A1 - Bakuchiol compositions for treatment of post inflammatory hyperpigmentation - Google Patents

Bakuchiol compositions for treatment of post inflammatory hyperpigmentation

Info

Publication number
PH12013501632A1
PH12013501632A1 PH1/2013/501632A PH12013501632A PH12013501632A1 PH 12013501632 A1 PH12013501632 A1 PH 12013501632A1 PH 12013501632 A PH12013501632 A PH 12013501632A PH 12013501632 A1 PH12013501632 A1 PH 12013501632A1
Authority
PH
Philippines
Prior art keywords
treatment
inflammatory hyperpigmentation
bakuchiol
post inflammatory
disclosed
Prior art date
Application number
PH1/2013/501632A
Other languages
English (en)
Inventor
Lidia Alfaro Brownell
Mei Feng Hong
Qi Jia
Original Assignee
Unigen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unigen Inc filed Critical Unigen Inc
Priority claimed from PCT/US2012/023686 external-priority patent/WO2012106551A1/fr
Publication of PH12013501632A1 publication Critical patent/PH12013501632A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/30—Characterized by the absence of a particular group of ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PH1/2013/501632A 2011-02-02 2012-02-02 Bakuchiol compositions for treatment of post inflammatory hyperpigmentation PH12013501632A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161438890P 2011-02-02 2011-02-02
PCT/US2011/026594 WO2012105990A1 (fr) 2011-02-02 2011-03-01 Compositions de bakuchiol pour le traitement d'une hyperpigmentation post-inflammatoire
PCT/US2012/023686 WO2012106551A1 (fr) 2011-02-02 2012-02-02 Compositions de bakuchiol pour le traitement d'une hyperpigmentation post-inflammatoire

Publications (1)

Publication Number Publication Date
PH12013501632A1 true PH12013501632A1 (en) 2019-03-22

Family

ID=46603028

Family Applications (1)

Application Number Title Priority Date Filing Date
PH1/2013/501632A PH12013501632A1 (en) 2011-02-02 2012-02-02 Bakuchiol compositions for treatment of post inflammatory hyperpigmentation

Country Status (8)

Country Link
KR (5) KR102525516B1 (fr)
CN (2) CN103458882B (fr)
AU (1) AU2012212153B9 (fr)
BR (1) BR112013019798A2 (fr)
CA (4) CA2826262C (fr)
MX (1) MX350719B (fr)
PH (1) PH12013501632A1 (fr)
WO (1) WO2012105990A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10471035B2 (en) 2014-10-20 2019-11-12 Sunny BioDiscovery Compositions and methods for using esters of meroterpenes and of other resveratrol analogues
CN105675741A (zh) * 2015-12-30 2016-06-15 成都九芝堂金鼎药业有限公司 一种测定生发丸中有效成分含量的方法
KR20190116858A (ko) 2018-04-05 2019-10-15 주식회사 엑소코바이오 줄기세포 유래의 엑소좀 및/또는 세포외 소포체를 유효성분으로 포함하는 조성물의 염증후 과색소침착의 예방, 완화, 감소 내지는 제거 용도
KR102610938B1 (ko) 2018-08-31 2023-12-08 (주)아모레퍼시픽 유화입자를 형성하는 나노캡슐 및 이를 포함하는 유화 조성물
KR102887367B1 (ko) * 2020-02-27 2025-11-14 (주)아모레퍼시픽 보습 효과를 갖는 조성물
CN111544317B (zh) * 2020-04-29 2022-01-14 珀莱雅化妆品股份有限公司 一种抗衰老组合物阳离子纳米脂质体及其制备方法与应用
CN114478196B (zh) * 2021-01-27 2023-11-10 江苏巴帝恩生物科技有限公司 一种从春榆根里提取补骨脂酚并纯化的方法及在化妆品中的应用
US20250018312A1 (en) * 2023-07-03 2025-01-16 Anju Majeed Furanocoumarins free bakuchiol compositions and their method of preparation thereof
CN117771298A (zh) * 2023-11-23 2024-03-29 常州大学 一种具有抗黑色素生成活性的组合物及其制备方法
KR102899265B1 (ko) * 2024-03-29 2025-12-10 한국세라믹기술원 항산화 및 항염 활성이 개선된 바쿠치올 나노입자의 제조 방법 및 상기 방법에 의해 제조된 바쿠치올 나노입자의 용도

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2617473B2 (ja) 1987-06-30 1997-06-04 キヤノン株式会社 情報入力装置
CN101217968B (zh) * 2005-05-09 2014-11-26 尤尼根公司 补骨脂酚的组合物及其制备方法
WO2008140673A1 (fr) * 2007-05-14 2008-11-20 Sytheon Ltd. Compositions de traitement pour la peau et procédés

Also Published As

Publication number Publication date
CA2826262A1 (fr) 2012-08-09
AU2012212153A1 (en) 2013-08-29
CA3128718A1 (fr) 2012-08-09
KR102525516B1 (ko) 2023-04-24
KR20230058727A (ko) 2023-05-03
KR102642352B1 (ko) 2024-02-28
CA3128715A1 (fr) 2012-08-09
HK1215792A1 (zh) 2016-09-15
CN105147533B (zh) 2018-07-31
WO2012105990A1 (fr) 2012-08-09
KR102156731B1 (ko) 2020-09-16
KR101954118B1 (ko) 2019-03-05
CA3128711A1 (fr) 2012-08-09
KR102333655B1 (ko) 2021-12-01
AU2012212153B2 (en) 2017-04-06
MX2013008890A (es) 2013-10-17
BR112013019798A2 (pt) 2017-07-04
KR20210145864A (ko) 2021-12-02
KR20140008364A (ko) 2014-01-21
CA3128711C (fr) 2026-03-10
KR20200108120A (ko) 2020-09-16
KR20190025740A (ko) 2019-03-11
CN103458882B (zh) 2015-08-05
CN105147533A (zh) 2015-12-16
MX350719B (es) 2017-09-14
CA2826262C (fr) 2021-10-26
AU2012212153B9 (en) 2017-05-11
CN103458882A (zh) 2013-12-18

Similar Documents

Publication Publication Date Title
WO2012106551A1 (fr) Compositions de bakuchiol pour le traitement d'une hyperpigmentation post-inflammatoire
PH12013501632A1 (en) Bakuchiol compositions for treatment of post inflammatory hyperpigmentation
IN2015DN02573A (fr)
EP4647076A3 (fr) Composés thérapeutiquement actifs et leurs procédés d'utilisation
MX366955B (es) Crlx101 para usarse en el tratamiento de cáncer.
GB201118656D0 (en) New compounds
IN2014DN09434A (fr)
IN2015DN01119A (fr)
UA113541C2 (xx) Заміщені піролідин-2-карбоксаміди
PH12014500943A1 (en) Combination treatment of cancer
IN2014DN06104A (fr)
PH12018500071B1 (en) Plinabulin compositions
PH12016500136A1 (en) Positive allosteric modulators of nicotinic acetylcholine receptor
EA032271B9 (ru) Вещества, фармацевтическая композиция и методы применения при лечении воспалительных заболеваний
PH12014500990A1 (en) Methods for treating gout flares
BR112016029012A2 (pt) método de tratamento de câncer de pulmão de células não pequenas e/ou câncer de pulmão de células pequenas usando compostos de tienotriazolodiazepina
PH12014500057A1 (en) Positive allosteric modulators of nicotinic acetylcholine receptor
HK1216095A1 (zh) 烟碱乙酰胆碱受体的新的正向别构调节剂
MX2015001488A (es) Tratamiento de la inflamacion utilizando serelaxina.
WO2012006585A3 (fr) Utilisation de l'interleukine-15 dans le traitement de maladies cardiovasculaires
PH12014500739B1 (en) Methods for treating a stroke-related sensorimotor impairment using aminopyridines
GB201022049D0 (en) Methods
WO2012112862A3 (fr) Traitement d'une infection mycobactérienne à l'aide de composés thérapeutiques amplifiant cu+/cu++
WO2014015137A3 (fr) Compositions et méthodes de traitement de maladies dysprolifératives
BR112013025610A2 (pt) uso de um metapneumovírus aviário vivo, e, composição farmacêutica